miR-663 could inhibit proliferation and invasion of glioblastoma in vitro and in vivo by directly targeting PIK3CD, thus, reducing the expression of three downstream effectors: CCND1, MMP2 and MMP7 (26). Here, PIK3CD is linked to glioblastoma.